Comments

Regenxbio Stock Price, Quotes and Forecasts

Q: What sector and industry does Regenxbio (RGNX) operate in?

Regenxbio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

RGNXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$8.56

0.708.91%

At close: -

$8.50

-0.06-0.70%

After Hours: 5:02 PM EDT

Regenxbio (RGNX) Forecast

News Earnings Regenxbio (RGNX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Regenxbio Stock Price, Quotes and Forecasts | NASDAQ:RGNX | Benzinga

Explore Regenxbio stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for RGNX.

Open	$7.97
Close	$8.56
Volume / Avg.	935.08K / 1.16M
Day Range	$7.85 - $8.61
52 Wk Range	5.04 - 15.36
Market Cap	$428.30M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	46
Short Interest	14.52%
Days to Cover	5.62

Recent News

Crude Oil Moves Higher; Ciena Posts Downbeat Earnings

Avi Kapoor

Early Wins: RegenXBio's Gene Therapy Helps Duchenne Patients Walk Stronger, Longer

RegenXBio's RGX-202 gene therapy improved function in Duchenne patients at 9 and 12 months, supporting a 2026 BLA filing and 2027 launch.

Vandana Singh

Dow Dips Over 100 Points; US Jobless Claims Increase

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Feb

Mar

Apr

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$7.97
Close	$8.56
Volume / Avg.	935.08K / 1.16M
Day Range	$7.85 - $8.61
52 Wk Range	5.04 - 15.36
Market Cap	$428.30M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	46
Short Interest	14.52%
Days to Cover	5.62

About Regenxbio Inc

Sector

Health Care

Industry

Biotechnology

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Regenxbio (RGNX) stock?

You can purchase shares of Regenxbio (NASDAQ:RGNX) through any online brokerage.

View our list of the best stock brokerages

Who are Regenxbio (RGNX) competitors?

Other companies in Regenxbio’s space includes: Tectonic Therapeutic (NASDAQ:TECX), Precigen (NASDAQ:PGEN), Celcuity (NASDAQ:CELC), Cellectar Biosciences (NASDAQ:CLRB) and aTyr Pharma (NASDAQ:ATYR).

What is the forecast, or price target, for Regenxbio (RGNX) stock?

Regenxbio has a consensus price target of $32.50.

What is the current price for Regenxbio (RGNX)?

The stock price for Regenxbio (NASDAQ: RGNX) is $8.5 last updated June 24, 2025 at 5:02 PM EDT.

Does Regenxbio (RGNX) pay a dividend?

There are no upcoming dividends for Regenxbio.

When is Regenxbio (NASDAQ:RGNX) reporting earnings?

Regenxbio’s Q2 earnings are confirmed for Thursday, July 31, 2025.

Is Regenxbio (RGNX) going to split?

There is no upcoming split for Regenxbio.

What sector and industry does Regenxbio (RGNX) operate in?

Regenxbio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.